Durvalumab Long-Term Safety and Efficacy Study

PHASE4CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

September 5, 2019

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2024

Conditions
Solid Tumor
Interventions
DRUG

Durvalumab

IV infusion q4w with 1500mg durvalumab until progressive disease

Trial Locations (116)

704

Research Site, Tainan City

1011

Research Site, Lausanne

1090

Research Site, Brussels

1121

Research Site, Budapest

1307

Research Site, Dresden

1612

Research Site, Sofia

3000

Research Site, Melbourne

Research Site, Leuven

3128

Research Site, Box Hill

3526

Research Site, Miskolc

8112

Research Site, Kyiv

8500

Research Site, Kortrijk

10330

Research Site, Bangkok

11217

Research Site, Taipei

11501

Research Site, Mineola

13620

Research Site, Seongnam-si

17007

Research Site, Girona

20007

Research Site, Washington D.C.

21029

Research Site, Vinnytsia

21201

Research Site, Baltimore

21204

Research Site, Kamenitz

23007

Research Site, Jaén

23561

Research Site, New Taipei City

25006

Research Site, Kirovohrad

27514

Research Site, Chapel Hill

28041

Research Site, Madrid

28046

Research Site, Madrid

28078

Research Site, Huntersville

29010

Research Site, Málaga

29600

Research Site, Marbella

29605

Research Site, Greenville

29609

Research Site, Brest

30625

Research Site, Hanover

30912

Research Site, Augusta

34098

Research Site, Istanbul

37203

Research Site, Nashville

40005

Research Site, Sumy

40447

Research Site, Taichung

40705

Research Site, Taichung

41931

Research Site, Daegu

46026

Research Site, Valencia

49241

Research Site, Seogu

50048

Research Site, Kryvyi Rih

52727

Research Site, Gyeongsangnam-do

55407

Research Site, Minneapolis

58013

Research Site, Chernivtsі

59037

Research Site, Lille

61070

Research Site, Kharkiv

61469

Research Site, Gwangju

63110

Research Site, St Louis

69373

Research Site, Lyon

75251

Research Site, Dallas

76018

Research Site, Ivano-Frankivsk

88014

Research Site, Uzhhorod

90110

Research Site, Songkhla

91096

Research Site, Haifa

92835

Research Site, Fullerton

93586

Research Site, Kuching

100000

Research Site, Hanoi

111123

Research Site, Moscow

115280

Research Site, Moscow

163045

Research Site, Arkhangelsk

197022

Research Site, Saint Petersburg

197758

Research Site, pos.Pesochnyi

Research Site, Saint Petersburg

200347

Research Site, Craiova

600006

Research Site, Chennai

644013

Research Site, Omsk

720237

Research Site, Suceava

7500000

Research Site, Santiago

S2000KZE

Research Site, Rosario

88034-000

Research Site, Florianópolis

98700-000

Research Site, Ijuí

90035-903

Research Site, Porto Alegre

15090-000

Research Site, São José do Rio Preto

T2N 4N2

Research Site, Calgary

M5G 2M9

Research Site, Toronto

P3E 5J1

Research Site, Greater Sudbury

L3Y 2P9

Research Site, Newmarket

775 20

Research Site, Olomouc

155 62

Research Site, Holargos, Athens

113-8677

Research Site, Bunkyō City

960-1295

Research Site, Fukushima

259-1193

Research Site, Isehara-shi

594-0073

Research Site, Izumi-shi

596-8501

Research Site, Kishiwada-shi

135-8550

Research Site, Kōtoku

940-2085

Research Site, Nagaoka-shi

466-8560

Research Site, Nagoya

981-1293

Research Site, Natori-shi

700-8558

Research Site, Okayama

541-8567

Research Site, Osaka

840-8571

Research Site, Saga

565-0871

Research Site, Suita-shi

411-8777

Research Site, Sunto-gun

770-8503

Research Site, Tokushima

241-8515

Research Site, Yokohama

1066 CX

Research Site, Amsterdam

6815 AD

Research Site, Arnhem

90-302

Research Site, Lodz

93-509

Research Site, Lodz

10-357

Research Site, Olsztyn

03080

Research Site, Seoul

03722

Research Site, Seoul

06351

Research Site, Seoul

08916

Research Site, Badalona

08028

Research Site, Barcelona

08035

Research Site, Barcelona

08041

Research Site, Barcelona

CH-6500

Research Site, Bellinzona

01120

Research Site, Adana

03022

Research Site, Kyiv

03115

Research Site, Kyiv

EC1A 7BE

Research Site, London

WC1N 3BG

Research Site, London

M20 4BX

Research Site, Manchester

Sponsors

Lead Sponsor

Collaborators (2)

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

collaborator

Parexel

INDUSTRY

collaborator

Medidata Solutions

INDUSTRY

collaborator

CISCRP

INDUSTRY

lead

AstraZeneca

INDUSTRY